Buy Celsentri Tablets Online

Celsentri is a brand-name HIV medication that contains maraviroc, a CCR5 antagonist used with other antiretroviral medicines. Celsentri tablets can be bought online, with current strengths and quantities shown during ordering so the medicine can be matched to the directions set by your HIV care team. U.S. customers may use US delivery from Canada when arranging a cash-pay supply of this regulated pharmacy medicine.

Celsentri Price and Tablet Strengths

The Celsentri price depends on the tablet strength, quantity, brand or generic supply, and the order total shown at checkout. The most useful Celsentri cost comparison is the full amount for the exact maraviroc tablet strength your treatment plan uses, rather than a broad estimate from another pack size or country.

Commonly published tablet strengths include Celsentri 150 mg and Celsentri 300 mg. Generic maraviroc tablets may appear separately when available through the catalog. If both brand and generic choices are displayed, compare the active ingredient, strength, tablet count, and country information before choosing.

Quick tip: Match the strength first, then evaluate the total order amount.

How to Order Celsentri Online

Choose the Celsentri tablets that correspond to your current HIV regimen, then enter order information carefully. The strength, quantity, shipping address, and contact details should be accurate so the pharmacy can process the order without avoidable delays.

Some people compare Celsentri without insurance because cash-pay pricing can vary widely between sources. When comparing Celsentri price US delivery from Canada, focus on the same strength and the same number of tablets. A lower total is only useful if the medicine still fits the regimen already established by your clinician.

Do not adjust tablet strength, dose timing, or companion medicines to make an order fit a different supply. Maraviroc is part of combination HIV therapy, and changes can affect the whole regimen. If the exact strength you use is not available during ordering, ask your HIV care team whether another maraviroc tablet or a different antiretroviral combination is appropriate.

What Celsentri Treats

Celsentri is an HIV-1 medication used with other antiretroviral medicines for virus confirmed to be CCR5-tropic. CCR5-tropic means the virus uses a CCR5 co-receptor on immune cells to enter those cells. A tropism test helps determine whether maraviroc is a suitable entry-inhibitor choice.

This medicine is not used alone. It is also not intended for HIV prevention before exposure, and it does not treat HIV that uses CXCR4 or dual/mixed entry pathways. If viral load does not respond as expected, the care team may repeat resistance or tropism testing to reassess whether maraviroc remains useful.

The HIV category can help you keep related treatment pages organized. Broader medication browsing is available through Antivirals, which groups antiviral products by class-level navigation.

Maraviroc Class and How It Works

Maraviroc is a CCR5 antagonist medication, also called an HIV entry inhibitor. Instead of blocking a viral enzyme after HIV enters a cell, it binds to the CCR5 co-receptor on certain immune cells. This may prevent CCR5-tropic HIV-1 from entering those cells.

The class is different from integrase inhibitors, protease inhibitors, non-nucleoside reverse transcriptase inhibitors, and nucleoside reverse transcriptase inhibitors. Those medicines target other steps in the HIV life cycle. Maraviroc may be used when the virus entry pattern, treatment history, resistance results, and drug-interaction profile make it a reasonable part of a complete regimen.

Why it matters: Tropism testing helps avoid using maraviroc when the virus is unlikely to respond.

Strengths, Dosing, and Tablet Use

Celsentri tablets are film-coated oral tablets. Published presentations include Celsentri 150 mg and Celsentri 300 mg, while generic maraviroc 150 mg or maraviroc 300 mg may appear as separate products when stocked. Availability of a specific strength can change with supply.

Celsentri dosage is not chosen by preference. Maraviroc exposure can change when it is used with strong CYP3A inhibitors, strong CYP3A inducers, and certain antiretroviral combinations. Kidney and liver factors may also affect how the medication is selected and monitored.

• 150 mg tablets: may be used in some regimens involving strong CYP3A inhibitors.
• 300 mg tablets: often appear in standard tablet supply choices.
• Twice-daily use: common labeling describes oral dosing with or without food.
• Combination therapy: other antiretroviral medicines remain essential.

Swallow tablets whole with water unless your care team gives different instructions. If you miss a dose, follow the patient instructions supplied with your medicine or contact a pharmacist. Do not double doses unless a healthcare professional specifically tells you to do so.

Brand and Generic Maraviroc

Celsentri is the brand name for maraviroc. Depending on market and supply, maraviroc tablets may also be sold as a generic medicine. Brand and generic names can differ by country, and U.S. references may also use the brand name Selzentry for maraviroc.

If generic maraviroc is offered alongside Celsentri, compare the practical pharmacy attributes: active ingredient, strength, tablet count, manufacturer, and country information when shown. The decision should be based on the medicine your regimen calls for and any substitution guidance from your care team.

Country information may be useful for personal medication records. When origin details are relevant, the Canada attribute page can help with catalog navigation.

Storage, Travel, and Delivery Planning

Store Celsentri tablets at room temperature in the original container, away from excess heat and moisture. Keep the bottle tightly closed. As with all HIV medicines, keep tablets out of reach of children and pets, and do not use tablets that are damaged or past the labeled expiration date.

For travel, carry tablets in labeled packaging and keep them in hand luggage when possible. Bring a medication list and a copy of the instructions from your care team, especially when crossing borders or seeing a new clinician. Refill planning matters because interruptions can affect the full antiretroviral regimen.

Orders may offer prompt, express shipping when available, but shipment speed should not replace early refill planning. Check the package contents after arrival, keep the label, and store the medication according to the instructions on the container.

Side Effects, Warnings, and Monitoring

Common side effects reported with maraviroc can include cough, upper respiratory symptoms, nausea, diarrhea, stomach discomfort, headache, dizziness, tiredness, rash, itching, and muscle or joint aches. Many effects are mild, but persistent, severe, or worsening symptoms should be discussed with the care team that manages your HIV treatment.

Serious risks can include liver problems, severe skin or hypersensitivity reactions, postural hypotension, and cardiovascular events. Warning signs such as yellow skin or eyes, dark urine, severe fatigue, blistering rash, mouth sores, facial swelling, breathing trouble, chest pain, fainting, or unusual shortness of breath need urgent medical attention.

• Liver safety: hepatitis history or abnormal liver tests may require closer monitoring.
• Blood pressure: dizziness on standing may reflect postural hypotension.
• Skin reactions: blistering, peeling, or mouth sores can be serious.
• Immune changes: immune reconstitution syndrome may reveal hidden infections.
• Adherence: missed or inconsistent doses can affect the whole regimen.

Monitoring commonly includes viral load, CD4 count, safety labs, side-effect assessment, and medication-list review. If viral suppression is not maintained, additional testing may be needed to evaluate resistance, tropism, or adherence barriers.

Interactions and Precautions

Maraviroc is mainly metabolized by CYP3A. Strong CYP3A inhibitors can raise maraviroc levels, while strong CYP3A inducers can lower them. This interaction pattern is one reason Celsentri 150 mg, Celsentri 300 mg, and other maraviroc dosing choices must be interpreted within the full treatment plan.

Avoid St John’s wort unless your clinician specifically approves it, because it can reduce levels of many medicines processed through CYP pathways. Medicines that lower blood pressure may increase dizziness or fainting risk in some people. Kidney disease, liver disease, cardiovascular risk, and complex HIV regimens all call for careful review.

Tell your healthcare team about prescription medicines, over-the-counter products, supplements, and recreational substances. The safest antiretroviral plan depends on the complete medication list, not only on the HIV medicines.

Related HIV Treatment Decisions

Celsentri is usually considered within a broader HIV treatment strategy. Nearby options may include integrase inhibitors, nucleoside reverse transcriptase inhibitors, non-nucleoside reverse transcriptase inhibitors, protease inhibitors, or other agents selected according to treatment history and resistance results.

Maraviroc differs from a complete single-tablet regimen because it is an entry inhibitor used with companion antiretrovirals. If you are switching medicines because of tolerability, interactions, viral load results, or cost concerns, ask your HIV care team how each medicine contributes to the full regimen.

Delstrigo, mentioned often in HIV treatment questions, is a complete regimen for some people because it combines multiple antiretroviral agents in one tablet. Celsentri is different: it contains maraviroc only and must be paired with other active HIV medicines when used for treatment.

Authoritative Sources

These sources support the medication class, treatment-use context, and safety points summarized above:

• Official regulator overview: European Medicines Agency Celsentri
• Canadian patient information: CATIE maraviroc and Celsentri
• Canadian product monograph: Celsentri product monograph

Use the official label and your clinician’s instructions when dose directions, interaction advice, or safety information differ from a general summary. Keep your HIV care team informed about every medicine and supplement you use.

This content is for informational purposes only and is not a substitute for professional medical advice.